Literature DB >> 17660267

Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects.

Helen Karakelides1, Yan W Asmann, Maureen L Bigelow, Kevin R Short, Ketan Dhatariya, Jill Coenen-Schimke, Jane Kahl, Debabrata Mukhopadhyay, K Sreekumaran Nair.   

Abstract

OBJECTIVE: Muscle mitochondrial dysfunction occurs in many insulin-resistant states, such as type 2 diabetes, prompting a hypothesis that mitochondrial dysfunction may cause insulin resistance. We determined the impact of insulin deficiency on muscle mitochondrial ATP production by temporarily depriving type 1 diabetic patients of insulin treatment. RESEARCH DESIGN AND METHODS: We withdrew insulin for 8.6 +/- 0.6 h in nine C-peptide-negative type 1 diabetic subjects and measured muscle mitochondrial ATP production and gene transcript levels (gene array and real-time quantitative PCR) and compared with insulin-treated state. We also measured oxygen consumption (indirect calorimetry); plasma levels of glucagon, bicarbonate, and other substrates; and urinary nitrogen.
RESULTS: Withdrawal of insulin resulted in increased plasma glucose, branched chain amino acids, nonesterified fatty acids, beta-hydroxybutyrate, and urinary nitrogen but no change in bicarbonate. Insulin deprivation decreased muscle mitochondrial ATP production rate (MAPR) despite an increase in whole-body oxygen consumption and altered expression of many muscle mitochondrial gene transcripts. Transcript levels of genes involved in oxidative phosphorylation were decreased, whereas those involved in vascular endothelial growth factor (VEGF) signaling, inflammation, cytoskeleton signaling, and integrin signaling pathways were increased.
CONCLUSIONS: Insulin deficiency and associated metabolic changes reduce muscle MAPR and expression of oxidative phosphorylation genes in type 1 diabetes despite an increase in whole-body oxygen consumption. Increase in transcript levels of genes involved in VEGF, inflammation, cytoskeleton, and integrin signaling pathways suggest that vascular factors and cell proliferation that may interact with mitochondrial changes occurred.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660267     DOI: 10.2337/db07-0378

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  54 in total

1.  Release of skeletal muscle peptide fragments identifies individual proteins degraded during insulin deprivation in type 1 diabetic humans and mice.

Authors:  Matthew M Robinson; Surendra Dasari; Helen Karakelides; H Robert Bergen; K Sreekumaran Nair
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-19       Impact factor: 4.310

2.  Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis.

Authors:  Thomas S Voss; Mikkel H Vendelbo; Ulla Kampmann; Steen B Pedersen; Thomas S Nielsen; Mogens Johannsen; Mads V Svart; Niels Jessen; Niels Møller
Journal:  Diabetologia       Date:  2018-12-01       Impact factor: 10.122

Review 3.  Insulin Regulation of Proteostasis and Clinical Implications.

Authors:  Haleigh A James; Brian T O'Neill; K Sreekumaran Nair
Journal:  Cell Metab       Date:  2017-07-14       Impact factor: 27.287

Review 4.  Regulation of skeletal muscle mitochondrial function: genes to proteins.

Authors:  I R Lanza; K Sreekumaran Nair
Journal:  Acta Physiol (Oxf)       Date:  2010-03-25       Impact factor: 6.311

5.  Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension.

Authors:  Simon Malenfant; François Potus; Frédéric Fournier; Sandra Breuils-Bonnet; Aude Pflieger; Sylvie Bourassa; Ève Tremblay; Benjamin Nehmé; Arnaud Droit; Sébastien Bonnet; Steeve Provencher
Journal:  J Mol Med (Berl)       Date:  2014-12-30       Impact factor: 4.599

6.  Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo.

Authors:  Thiago M Batista; Ruben Garcia-Martin; Weikang Cai; Masahiro Konishi; Brian T O'Neill; Masaji Sakaguchi; Jong Hun Kim; Dae Young Jung; Jason K Kim; C Ronald Kahn
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

7.  The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans.

Authors:  Vicencia Sales; Mary-Elizabeth Patti
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-12-09

8.  Interdependence of signal processing and analysis of urine 1H NMR spectra for metabolic profiling.

Authors:  Shucha Zhang; Cheng Zheng; Ian R Lanza; K Sreekumaran Nair; Daniel Raftery; Olga Vitek
Journal:  Anal Chem       Date:  2009-08-01       Impact factor: 6.986

9.  Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes.

Authors:  Ian R Lanza; Shucha Zhang; Lawrence E Ward; Helen Karakelides; Daniel Raftery; K Sreekumaran Nair
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

10.  Excessive loss of skeletal muscle mass in older adults with type 2 diabetes.

Authors:  Seok Won Park; Bret H Goodpaster; Jung Sun Lee; Lewis H Kuller; Robert Boudreau; Nathalie de Rekeneire; Tamara B Harris; Stephen Kritchevsky; Frances A Tylavsky; Michael Nevitt; Yong-wook Cho; Anne B Newman
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.